GlassScriptPhysician profile
Elizabeth Johnson
NPI 1770766842
$2,723.79
in general payments reported to CMS, 2019-2025
13 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,651 · 2022: $68.23 · 2023: $115 · 2024: $576 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,004.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $1,464.53 | 2021 | |
| Saluda Medical Americas, INC. | $326.13 | 2024-2025 | Evoke |
| Neurocrine Biosciences, INC. | $204.70 | 2023-2024 | Ingrezza, Ongentys |
| Nevro Corp. | $147.96 | 2021 | |
| Ucb, INC. | $128.18 | 2023-2025 | Briviact, Rystiggo |
| Abbvie INC. | $124.99 | 2025 | |
| Sk Life Science, INC. | $108.60 | 2024-2025 | |
| Boston Scientific Corporation | $58.25 | 2021-2022 | |
| Esperion Therapeutics, INC. | $48.75 | 2022 | |
| Octapharma USA, INC. | $39.26 | 2024 | Panzyga |
| Caris Mpi, INC. | $26.58 | 2025 | Mi Cancer Seek |
| Globus Medical, INC. | $25.13 | 2025 | Coalition Agx, Bendini, Reline |
| Argenx US, INC. | $20.73 | 2025 | Vyvgart, Vyvgart Hytrulo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.